Supplementary data for: "Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii
Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen. Colistin-re...
The increasing incidence and emergence of multi-drug resistant (MDR) Acinetobacter baumannii has bec...
SummaryBackgroundIn recent years there has been an increase in life-threatening infections caused by...
This study was performed to investigate the mechanisms of in vivo acquisition of colistin resistance...
Acinetobacter baumannii is an important opportunistic nosocomial pathogen often resistant to multipl...
The colistin resistance mechanisms in Acinetobacter baumannii are largely unknown. In the present st...
The increasing incidence and emergence of multi-drug resistant (MDR) Acinetobacter baumannii has bec...
The spread of extensively drug-resistant (XDR) gram-negative bacteria has boosted colistin use, with...
Even though colistin-based treatment represents the antimicrobial-regimen backbone for the managemen...
Copyright © 2009 The British Infection Society Published by Elsevier Ltd.Background Multidrug-resist...
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant organism due...
Acinetobacter baumannii is a significant cause of opportunistic hospital acquired infection and has ...
Even though colistin-based treatment represents the antimicrobial-regimen backbone for the managemen...
Even though colistin-based treatment represents the antimicrobial-regimen backbone for the managemen...
Even though colistin-based treatment represents the antimicrobial-regimen backbone for the managemen...
Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen. Colistin-re...
The increasing incidence and emergence of multi-drug resistant (MDR) Acinetobacter baumannii has bec...
SummaryBackgroundIn recent years there has been an increase in life-threatening infections caused by...
This study was performed to investigate the mechanisms of in vivo acquisition of colistin resistance...
Acinetobacter baumannii is an important opportunistic nosocomial pathogen often resistant to multipl...
The colistin resistance mechanisms in Acinetobacter baumannii are largely unknown. In the present st...
The increasing incidence and emergence of multi-drug resistant (MDR) Acinetobacter baumannii has bec...
The spread of extensively drug-resistant (XDR) gram-negative bacteria has boosted colistin use, with...
Even though colistin-based treatment represents the antimicrobial-regimen backbone for the managemen...
Copyright © 2009 The British Infection Society Published by Elsevier Ltd.Background Multidrug-resist...
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant organism due...
Acinetobacter baumannii is a significant cause of opportunistic hospital acquired infection and has ...
Even though colistin-based treatment represents the antimicrobial-regimen backbone for the managemen...
Even though colistin-based treatment represents the antimicrobial-regimen backbone for the managemen...
Even though colistin-based treatment represents the antimicrobial-regimen backbone for the managemen...
Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen. Colistin-re...
The increasing incidence and emergence of multi-drug resistant (MDR) Acinetobacter baumannii has bec...
SummaryBackgroundIn recent years there has been an increase in life-threatening infections caused by...